Nova review
The injection figures include a required care fee, and three of four rates changed between checks.
The verdict
Nova covers two states. Its injection rates include a required care fee. Three of its four figures moved between checks, the injections upward.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Rises with dose
- States
- 2
- Injection
- From $229/mo
- Oral
- From $139/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Nova sells compounded semaglutide and compounded tirzepatide in two forms. Injectable semaglutide is $229 a month. The oral is $139. Injectable tirzepatide is $279 and its oral is $159. Two states are served.
Who writes the prescription, and what do they see?
Treatment is arranged remotely. A prescription precedes the first shipment. The oral ships on provider approval. The pages do not describe who gives it.
The service is remote and every product is compounded. The injection rates are described as all-in: medication, shipping and a required Nova Care fee. A required fee named inside the price is better than one added at checkout.
What happens when the dose goes up?
The price scales with the dose. Nova says so. Most patients escalate inside sixteen weeks, so the opening figure is a starting point rather than a monthly cost.
What the price includes
Two things matter more than the headline. The first is the care fee. It is required, and Nova folds it into the injection figures rather than adding it at checkout. So $229 is closer to a real monthly cost than a bare medication rate. The second is movement. Injectable semaglutide went from $198 to $229 and tirzepatide from $210 to $279 between checks, while the orals fell. A price that moves that much in one interval is a price to confirm on the day.
What it claims, and what it cites
Both molecules are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. The oral tirzepatide is described as a sublingual microdose, and sublingual milligrams are not interchangeable with injectable milligrams. Nova states that itself.
Where it holds up, and where it does not
- Strength: Required care fee folded into the price
- Strength: Oral rates well below the injections
- Strength: Sublingual dosing difference stated plainly
- Limitation: Two states only
- Limitation: Injection rates rose between checks
- Limitation: Price scales with the dose
What the evidence says about this kind of treatment
The assessment above is about Nova. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader in one of the two states Nova covers who wants the service fee already inside the figure.
- Wrong for
- A reader outside those two states, and a reader who needs a rate that stays put.
How Nova compares
| Seller | Who it suits | Go |
|---|---|---|
| Wholesome Clinic | A reader who wants to see what a higher dose costs before starting, rather than discovering it in month three. | See Wholesome Clinic → |
| Zera Health | A reader who reads the dose qualifier before the figure, since the $129 line is described as low-dose rather than as the standing rate. | See Zera Health → |
 Revel Health | A reader who wants an oral and expects to pay less for it, which on this seller is what happens. | See Revel Health → |
More GLP-1 telehealth sellers reviews: Lean MedsLibertyMaximusNextMedsPallas HealthPlushCare
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What is the Nova Care fee?
- A required charge Nova folds into its injection rates rather than adding at checkout. It is why $229 is closer to a real monthly cost than a bare medication figure elsewhere.
- Did the prices change?
- Three of four moved between checks. Injectable semaglutide went from $198 to $229 and tirzepatide from $210 to $279. Both orals fell. Confirm the figure on the day.
- Is the sublingual dose the same as the injection?
- No, and Nova says so. Sublingual milligrams are not interchangeable with injectable milligrams.
- Is Nova expensive compared with other GLP-1 telehealth sellers?
- Nova publishes a starting figure of $139/mo. Across the 32 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $299 with a median of $139, which puts Nova right at the median. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.